FDA Adverse Event Malfunction Summary report: N

TREK CORONARY DILATATION CATHETER

MDR report key: 3150844 · Received June 6, 2013

Report

Report Number
2024168-2013-03555
Event Type
Malfunction
Date Received
June 6, 2013
Date of Event
May 17, 2013
Report Date
May 21, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
LOX
PMA / PMN Number
K103110
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TW
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE 3.0X15 NC TREK RX DILATATION CATHETER REFERENCED IS BEING FILED UNDER A SEPARATE MEDWATCH REPORT. IT IS INDICATED THAT THE DEVICE IS NOT RETURNING FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. THE LOT HISTORY RECORD FOR THIS PRODUCT COULD NOT BE REVIEWED AND A SIMILAR INCIDENT QUERY COULD NOT BE PERFORMED BECAUSE THE PART AND LOT NUMBERS WERE NOT REPORTED. BASED ON THE INFORMATION REVIEWED, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING THE PROCEDURE IN THE HEAVILY CALCIFIED PROXIMAL LEFT ANTERIOR DESCENDING ARTERY FOR TREATMENT OF A 80% STENOSIS, A NON-ABBOTT GUIDE WIRE WAS DELIVERED AND PRE-DILATATION WAS PERFORMED USING A 3.0X15 TREK BALLOON AT 14 ATMOSPHERES (ATMS). DUE TO THE HEAVY CALCIFICATION, THE BALLOON COULD NOT FULLY EXPAND; THEREFORE, THE DEVICE WAS WITHDRAWN AND PRE-DILATATION WAS PERFORMED AT 18 ATMS USING A 3.0X15 NC TREK RX DILATATION CATHETER. THE BALLOON COULD NOT FULLY EXPAND DUE TO THE HEAVY CALCIFICATION. THE DEVICE WAS WITHDRAWN FROM THE ANATOMY AND THE PATIENT WAS REFERRED FOR CORONARY ARTERY BYPASS SURGERY. THERE WAS NO ADVERSE PATIENT EFFECT AND NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
251208 TREK CORONARY DILATATION CATHETER CORONARY DILATATION CATHETER LOX AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 77 YR GUIDE WIRE: RUNTHROUGH